OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
42
Results
Show all
Save search
Copy query
Show results for
Unknown
(42)
Publication Date
Release Date
2021
(8)
2023
(6)
2019
(5)
2024
(4)
2018
(4)
2016
(4)
2020
(3)
2025
(2)
2022
(2)
2026
(1)
2017
(1)
2015
(1)
2010
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer-Simons syndrome).
Not available
S-EPMC8234012
|
biostudies-literature
Cite
Diagnosis and treatment of lipodystrophy: a step-by-step approach.
Not available
S-EPMC6304182
|
biostudies-literature
Cite
An Uncommon Association of Familial Partial Lipodystrophy, Dilated Cardiomyopathy, and Conduction System Disease.
Not available
S-EPMC4962337
|
biostudies-literature
Cite
LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
Not available
S-EPMC5120598
|
biostudies-literature
Cite
Effect of β-Estradiol on Adipogenesis in a 3T3-L1 Cell Model of Prelamin A Accumulation.
Not available
S-EPMC10816192
|
biostudies-literature
Cite
Lipodystrophic laminopathies: Diagnostic clues.
Not available
S-EPMC5973260
|
biostudies-literature
Cite
Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey.
Not available
S-EPMC11241872
|
biostudies-literature
Cite
Autoantibodies Against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy.
Not available
S-EPMC6156147
|
biostudies-literature
Cite
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy.
Not available
S-EPMC7340120
|
biostudies-literature
Cite
Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.
Not available
S-EPMC5936645
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets